GlobalData on MSN11d
ScreenPoint acquires Biomediq to bolster breast cancer risk assessment tool
With a decade-long collaboration history, the companies have previously demonstrated the value of their combined analysis ...
“Inside Edition”’s Alison Hall Says Reporting Olivia Munn’s Breast Cancer Led to Her Own Diagnosis: ‘Truly Miraculous’
The Breast Cancer Risk Assessment Tool (BCRAT), also known as The Gail Model, is a tool used by healthcare professionals to ...
How Olivia Munn's cancer journey sparked life-saving test for Alison Hall
"Inside Edition" correspondent Alison Hall opens up about her breast cancer battle and how Olivia Munn's own experience with ...
A Decade Younger: Why Indian Women Need Early Breast Cancer Screening
Apollo Hospitals offers a breast cancer risk assessment tool for Indian women to understand their risk and take proactive ...
News Medical on MSN3d
New NCCN patient resource shares latest understanding of genetic testing to guide patient decision making
NCCN—an alliance of leading cancer centers—publishes a new resource to inform people about the latest recommendations around ...
ScreenPoint Medical Acquires Biomediq A/S to Expand Breast Cancer Risk Assessment Capabilities
ScreenPoint Medical today announced the acquisition of Biomediq A/S, a research-based company focused on the research, ...
Women on Medicaid at Higher Risk of Breast Cancer
Breast cancer is the second leading cause of cancer death in women. Early detection results in 99% five-year survival rates.
The American Journal of Managed Care7d
Identifying Patients With Low-Risk Breast Cancer for De-escalated Therapy
A new analysis of the Breast Cancer Index (BCI) may help identify women with HR-positive breast cancer who could potentially ...
Rolling Out11d
3 crucial breast cancer warning signs Black women must know
Discover the 3 critical warning signs of breast cancer that every Black woman should know, plus insights on early detection ...
The American Journal of Managed Care5d
Breast Cancer Stage May Influence Risk of Prevalent CVD
Patient outcomes appeared to be more heavily driven by breast cancer stage than delays in diagnosis, researchers found.
Science Daily11d
Researchers resolve uncertainty in BRCA2 testing, improving cancer risk assessment and patient care
Findings from a multi-institutional, international study have significantly advanced the understanding of genetic alterations in the BRCA2 gene, a key player in hereditary cancer risk.